NIKKEI 225
38,179.46 -49.65 (-0.13%) HANG SENG
19,115.06 +151.38 (+0.80%) CRUDE OIL
78.89 +0.63 (+0.81%) GOLD FUTURES
2,342.70 -32.30 (-1.36%) DOW
39,453.13 -59.71 (-0.15%) Bitcoin GBP
49,925.39 +946.10 (+1.93%)
NeuroOne Medical Technologies Corporation (NMTC)
| Previous close | 1.1300 |
| Open | 1.1110 |
| Bid | 1.0700 x 100 |
| Ask | 1.1800 x 100 |
| Day's range | 1.1000 - 1.1600 |
| 52-week range | 0.8500 - 2.0000 |
| Volume | |
| Avg. volume | 210,380 |
| Market cap | 29.043M |
| Beta (5Y monthly) | 1.06 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GlobeNewswire
NeuroOne® to Report Second Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on May 14
EDEN PRAIRIE, Minn., May 10, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, will host a conference call and webcast on May 14, 2024 at 4:30 PM Eastern Time to discuss financial results for its second quarter of fiscal year 2024 ended March 31, 2024, and provide a corporate update. Conference Call
- GlobeNewswire
NeuroOne® CEO Dave Rosa Featured on Bloomberg Technology
EDEN PRAIRIE, Minn., April 10, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (“NeuroOne” or the “Company”), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announces an appearance by Chief Executive Officer Dave Rosa on Bloomberg Television's Bloomberg Technology. A replay of the segment, which aired live yesterday, can be viewed at NeuroOne-Bloomberg. In conversation with
- GlobeNewswire
NeuroOne® Announces First Implant of OneRF™ Ablation Electrodes
First to market FDA-cleared thin-film, sEEG-guided RF system capable of both recording electrical activity and ablating nervous tissue with the added benefit of temperature control EDEN PRAIRIE, Minn., April 09, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (“NeuroOne” or the “Company”), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced the first implant of i
